Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2Malnutrition 2Neoplasm Metastasis 1Hepatitis C, Chronic 1Gastrointestinal Neoplasms 1Fibrosis 1Carcinoma, Hepatocellular 1Cachexia 1Breast Neoplasms 1Abdominal Neoplasms 1

Interventions

Bevacizumab 9Oxaliplatin 7Irinotecan 6Fluorouracil 6Nivolumab 5Leucovorin 5Cetuximab 5Capecitabine 5pembrolizumab 4Sunitinib 4IFL protocol 4Drug Therapy 4Cisplatin 4encorafenib 3Pemetrexed 3Gemcitabine 3Folfox protocol 35,10-methylenetetrahydrofolic acid 3trebananib 2trastuzumab deruxtecan 2amminedichloro(2-methylpyridine)platinum(II) 2Ocoxin 2N-(2-fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonylaminopyridin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 2Levoleucovorin 2IDRX-42 2CGX1321 2130-nm albumin-bound paclitaxel 2zanidatamab 1ulixertinib 1tivozanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Gastrointestinal Neoplasms × Dietary Supplements × Clear all
NCT01894828 2013-07-10

Nutritional Supplementation in Patients With no Signs of Malnutrition

MedSource Polska

Phase 4 Unknown
200 enrolled
Gastrointestinal

Abdominal Neoplasms, Gastrointestinal Neoplasms, Neoplasm Metastasis, Malnutrition

Data powered by HemOnc (CC BY 4.0) Colophon âš¡